*By Chloe Aiello* In five to seven years, Tesla will be valued as a diversified "technology titan" rather than just as an automaker, Wedbush's Dan Ives told Cheddar on Monday. Wedbush rated Tesla ($TSLA) "outperform" and raised its 12-month price target on the company to $440 last week. Tesla shares jumped Thursday following the report. "I think it's a disruptive technology player, which is really our perspective and how we view Tesla. And that's why in our opinion it's similar to how we viewed Apple ($AAPL) going back to '07 with iPhones ー revolutionizing smartphones," Ives said. Wedbush analysts Ives and Strecker Backe attributed their bullishness to Model 3 production volume and profitability turning a corner. But Tesla's long-term viability has more to do with its potential to become a more diversified "technology titan." "Overall, seeing the forest through the trees, we believe Tesla has the most innovative product roadmap in the technology space over the next five to 10 years," Ives and Strecker wrote in their note. "Its flagship Model 3 \[is\] poised to catalyze a broader move to electronic vehicles, renewable energy, and eventually broader ambitions for Musk and Tesla that will lead to further innovations around battery production and self-driving cars looking out into 2020 and beyond." Of course, with controversial CEO Elon Musk at the helm of the company, the path forward will be a "bumpy road and never a smooth straight line," Ives wrote. But Ives said he doesn't consider Musk to be the greatest risk to the company. Rather, Ives said the biggest risk derives from Model 3 production. "Biggest risk is around production, specifically on Model 3. I think any bottleneck coming out of Freemont or Giga\[factory\], or any sort of major hiccup in terms of China, in terms of building Giga3, in terms of demand ー I think China's going to be key," Ives said. Tesla needs to maintain those numbers because it has a big opportunity to revolutionize on the consumer demand for cars in the mid-range with the Model 3. It's especially important considering it faces such stiff competition on electric vehicles from high-end automakers, like Mercedez, Jaguar, and Audi. Wedbush is just the latest Wall Street firm to upgrade its target on Tesla. Analysts from Jefferies and CFRA also upgraded the car maker earlier in the month, sparking a positive reaction from the shares. For full interview [click here](https://cheddar.com/videos/wedbush-securities-begins-tesla-coverage-with-outperform-rating).

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More